Q1 2024 revenue grew 17% year-over-year to NT$536.8 million, with net income doubling to NT$42.9 million and EPS rising to NT$1.03. Gross margin improved to 27%, and management expects continued growth in medical X-ray sensor demand.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.